
A Winning Bid
Founded in 1998, Emergent BioSolutions has gone on to become a multinational biopharma company – despite working in some difficult therapeutic areas, including biodefense.

False
Founded in 1998, Emergent BioSolutions has gone on to become a multinational biopharma company – despite working in some difficult therapeutic areas, including biodefense.
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
Jim Jackson is Chief Scientific Officer at Emergent BioSolutions.
False
False
December 1, 2014
0 min read
The Galactic Grant Competition encourages companies to use the International Space Station for pharmaceutical R&D
December 1, 2014
0 min read
Researchers estimate the cost of drug development at over $1 billion, while others say it’s less than $100 million. Who’s right? And how can we accurately determine the true costs?
December 2, 2014
0 min read
Electrochemical reaction cells are finding new applications in the pharma R&D lab that could offer big time and cost savings...
December 2, 2014
0 min read
Sitting Down With… William Chin, Executive Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA).
False